Welcome to our dedicated page for COGNEX SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Cognex Corporation reported governance updates from its 2026 annual meeting and a change in officer status. The board determined that Joerg Kuechen will no longer be treated as an “executive officer” under Exchange Act rules, and he will remain with the company as Head of Mergers and Acquisitions.
At the meeting, shareholders representing 153,890,280 of 167,013,856 shares outstanding as of the record date approved all proposals recommended by the board. Three directors—Matthew Moschner, Angelos Papadimitriou and Christopher Donato—were elected to terms ending in 2029. Shareholders also approved an amendment to the 2023 Stock Option and Incentive Plan, ratified KPMG LLP as independent registered public accounting firm for fiscal 2026, and gave advisory approval to executive compensation as described in the proxy statement.
Cognex Corp reported that Vanguard Capital Management disclosed beneficial ownership of 8,705,689 shares of Common Stock, representing 5.21% of the class. The filing states Vanguard has sole dispositive power over 8,705,689 shares and sole voting power for 1,275,533 shares. The filing is a Schedule 13G disclosure signed on 04/29/2026 and describes holdings held on behalf of Vanguard-managed funds and accounts.
Cognex Corp reports a Schedule 13G showing Vanguard Portfolio Management beneficially owns 10,390,950 shares of Common Stock. The filing states this equals 6.22% of the class and attributes dispositive power to Vanguard Portfolio Management LLC and affiliated business divisions. The filing lists 20,303 shares of sole voting power and affirms holdings are managed on behalf of multiple clients.
The Vanguard Group files an amendment stating it holds 0 shares (0%) of Cognex Corp common stock. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately. The statement is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.
COGNEX CORP director Christopher Donato filed an initial Form 3, which records his status as a reporting insider of the company. The filing reports no purchases, sales, or other transactions in Cognex stock, serving only as a baseline disclosure of his insider position.
COGNEX CORP director Sami Atiya filed an initial insider ownership report on the company’s stock. The filing is a Form 3, which establishes Atiya’s status as a director and provides a baseline disclosure of insider holdings. It reports no purchases, sales, exercises, gifts, or other transactions.
Cognex Corp VP and principal accounting officer Laura Ann MacDonald reported routine equity compensation activity. On March 15, 2026 she exercised 368 restricted stock units, receiving an equal number of common shares. Of these, 109 shares were automatically withheld at a price of $47.98 per share to cover tax obligations, leaving her with 7,470 common shares held directly after the transactions. Each restricted stock unit represents a right to one Cognex common share, and the grant vests approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the March 15, 2024 grant date.
Cognex Corporation is calling its 2026 annual shareholder meeting for April 29, 2026 at its Natick, Massachusetts headquarters. Shareholders of record on February 27, 2026, when 167,013,856 common shares were outstanding, may vote in person or by proxy.
Investors will vote on four proposals: electing three directors (Matthew Moschner, Angelos Papadimitriou, and Christopher Donato), approving an amendment to the 2023 Stock Option and Incentive Plan, ratifying the independent auditor, and an advisory say‑on‑pay resolution. The board recommends voting FOR all proposals.
The proxy details Cognex’s governance structure, board independence and committees, and a pay‑for‑performance philosophy emphasizing equity. In 2025, revenue grew 9%, operating margin improved from 12.6% to 16.3%, and the company returned $206 million to shareholders via dividends and buybacks, while tightening costs and revising executive bonus and PRSU designs for 2026.
Cognex director Dianne M. Parrotte exercised multiple non-qualified stock options on March 2, 2026 and immediately sold the resulting shares. She acquired 44,000 shares of Cognex common stock through option exercises at strike prices around $45–$51.49, then sold 44,000 shares in open-market transactions at $54.00 per share. After these transactions, she directly owned 33,431 Cognex common shares.